Glaxo SmithKline Biologicals sa

Rixensart, Belgium

Glaxo SmithKline Biologicals sa

Rixensart, Belgium
SEARCH FILTERS
Time filter
Source Type

Patent
Glaxo SmithKline Biologicals sa | Date: 2012-05-25

The present invention provides formulations of an immunogenic composition containing a purified inactivated Dengue virus, and method for producing them.


Patent
Glaxo Smith Kline Biologicals S.A. | Date: 2011-02-06

The present invention provides an immunogenic composition comprising one or more antigens and a Toll-like receptor (TLR) agonist in an orally (e.g. sublingually) administered composition.

Loading Glaxo SmithKline Biologicals sa collaborators
Loading Glaxo SmithKline Biologicals sa collaborators